BANDICOOT is an international adaptive platform trial (APT) designed to identify effective therapies that improve health outcomes for critically ill children receiving a haematopoetic stem cell transplant (HCT). Building
on extensive engagement with patients, their parents, and clinicians, we will launch 3 trial domains focused on exercise, nutritional supplementation, and the gut microbiome
Around a half of women in tuberculosis-endemic countries are infected with Mycobacterium tuberculosis and over 1.7 million females of reproductive age (15-45 years) fall ill with tuberculosis (TB) each year. Pregnancy is associated with an increased risk of TB disease which has major consequences for maternal health – TB is the major non-obstetric cause of maternal mortality globally – and for the health of their baby.
Genomics has moved rapidly from being purely a research tool to being part of routine care in many specialities and health services. Past Grand Round presenters have described how this has enhanced their service – how genomic care may improve patient outcomes, is cost-effective and can be delivered rapidly for acute cases.
Emma Livingstone, CEO of UP – The Adult Cerebral Palsy Movement, will share insights from her lived experience and advocacy work on the evolving care and understanding of cerebral palsy (CP) across the lifespan. Her presentation will explore recent research advancements, the lifelong nature of CP, and the importance of addressing co-morbidities. She will also discuss how child practitioners can better equip children with CP for adulthood.
There are real challenges in delivering equitable health care in a community, even when there is policy and service goodwill. This is an issue for health services around the world. For the past ten years BiBBS has been working alongside service partners and families to co-design, implement and evaluate multiple early years interventions that are delivered as a part of usual practice in disadvantaged inner-city areas in the UK.
In the last decade, we have seen genetic therapies leap from the benchtop into the neuromuscular clinic. This process is most dramatically illustrated by spinal muscular atrophy (SMA), which was until recently the most common genetic cause of death in infancy.
Opportunities exist to leverage implementation science and quality improvement science to advance quality care. During this presentation we will compare and contrast implementation science and quality improvement science. We will explore how methods from both fields have been used to improve our understanding of discharge communication practices in emergency departments in Canada.
Genomic medicine is rapidly evolving, yet many clinicians outside of clinical genetics face challenges in integrating these advances into routine practice. In this Grand Round, Associate Professor Catherine Quinlan explores her journey mainstreaming genomics in paediatric nephrology, using real-world data from Australia and Ireland and its implementation at The Royal Children’s Hospital.
Healthy Trajectories is proud to bring a celebration of the International Day of People with Disability (IDPwD) to Grand Rounds at The Royal Children’s Hospital. In line with our vision for an inclusive Australia, we will share what we and others around the Campus have been doing to authentically involve young people growing up with a disability, and their families, as partners in research.
Medical oxygen has been around for more than 200 years. It is a life-saving treatment we take for granted. Sadly this is not the case globally. The COVID-19 pandemic brought to the surface long-standing deficiencies. Images of patients gasping for oxygen reminded us that even today, 70% of patients who need oxygen globally do not receive it. How do we understand the different facets of this problem, and what can we do about it?
